Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kafia Belhocine

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Digestive Diseases (Basel, Switzerland)|May 15, 2009
Epidemiology of the complications of gastroesophageal reflux diseaseKafia Belhocine, Jean-Paul Galmiche
BMC Gastroenterology|July 17, 2014
Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazoleKafia Belhocine, Fabienne Vavasseur, Christelle Volteau, et al.
Gut|October 15, 2011
Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux diseaseFrank Zerbib, Kafia Belhocine, Mireille Simon, et al.
SAGE Open Medicine|April 29, 2026
Positivity rate of QuantiFERON-TB Gold Plus<sup>®</sup> test among candidates for biotherapy and factors influencing resultsHanane Mezenner, Hiba Ait Hamoudi, Soumia Naamoune, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Digestive Diseases (Basel, Switzerland)|May 15, 2009
Epidemiology of the complications of gastroesophageal reflux diseaseKafia Belhocine, Jean-Paul Galmiche
BMC Gastroenterology|July 17, 2014
Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazoleKafia Belhocine, Fabienne Vavasseur, Christelle Volteau, et al.
Gut|October 15, 2011
Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux diseaseFrank Zerbib, Kafia Belhocine, Mireille Simon, et al.
SAGE Open Medicine|April 29, 2026
Positivity rate of QuantiFERON-TB Gold Plus<sup>®</sup> test among candidates for biotherapy and factors influencing resultsHanane Mezenner, Hiba Ait Hamoudi, Soumia Naamoune, et al.
Pageof 1